SUBSCRIBE
SUBSCRIBE
News   FDA

Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Venlafaxine Extended Release Tablets

August 19, 2010 | 
1 min read
MUMBAI, India--(BUSINESS WIRE)--Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets.
FDA Approvals Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Sketch template design photo collage composite of computer monitor obsolete technology hand appear display hold speech cloud ask question.
Regulatory
Disc’s FDA Rejection Raises Questions About Commissioner’s Vouchers
February 18, 2026
 · 
4 min read
 · 
Dan Samorodnitsky
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
FDA
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
February 18, 2026
 · 
3 min read
 · 
Heather McKenzie
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie
illustration of doubtful man thinks whether to jump to the other side of the mountain, dilemma concept
Rare disease
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
February 17, 2026
 · 
3 min read
 · 
Annalee Armstrong